Related Experiment Videos
CD164--a novel sialomucin on CD34+ cells
1The MRC Molecular Haematology Unit, Institute of Molecular Medicine, The John Radcliffe Hospital, Oxford, UK. Swatt@worf.molbiol.ox.ac.uk
Leukemia & Lymphoma
|March 18, 2000
Summary
The sialomucin CD164, found on hematopoietic progenitor cells, plays a role in cell adhesion and may limit the proliferation of these cells during hematopoiesis.
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Hematopoiesis is regulated by interactions between receptors on hematopoietic progenitor cells and their microenvironment.
- Sialomucins, including CD164, are important in hematopoiesis and are found on primitive hematopoietic precursor cells.
- CD164 is a recently identified sialomucin highly expressed by primitive hematopoietic progenitor cells.
Purpose of the Study:
- To review the cloning, expression, and function of the sialomucin CD164.
- To understand CD164's role in hematopoietic progenitor cell adhesion and proliferation.
Main Methods:
- Literature review focusing on CD164.
- Analysis of CD164 expression on hematopoietic progenitor cells.
- Investigation of CD164's functional role in cell adhesion and proliferation.
Main Results:
- CD164 is highly expressed on primitive hematopoietic progenitor cells.
- CD164 mediates or regulates hematopoietic precursor cell adhesion to the bone marrow stroma.
- CD164 may act as a negative regulator of hematopoietic progenitor cell proliferation.
Conclusions:
- CD164 is a significant sialomucin in hematopoiesis.
- CD164 influences hematopoietic progenitor cell behavior, specifically adhesion and proliferation.
- Further research into CD164's function could reveal therapeutic targets for hematopoietic disorders.